Zobrazeno 1 - 10
of 19
pro vyhledávání: '"R H, Keith"'
Autor:
P. Adrian Evans, P. Rhodri Williams, Lisa J. Wakeman, Andrew Beddel, N. Thirumalai, Karl Hawkins, Roger C. Munro, M. S. Barrow, R. H. Keith Morris, Matthew Lawrence, D. J. Curtis, M. Rowan Brown
Publikováno v:
Rheologica Acta. 49:901-908
This study reports an automated numerical method for the location of the gel point in oscillatory shear data and demonstrates its potential application in measurements on therapeutically modified (heparinised) samples of healthy coagulating blood. He
Autor:
D. Spangler, James F Kachur, C. P. Anglin, Snyder Jp, Stella Siu-Tzyy Yu, T. D. Penning, S. W. Djuric, R H Keith, D. J. Fretland, Julie M Miyashiro
Publikováno v:
Journal of Medicinal Chemistry. 38:858-868
Our previous reports have highlighted the first-generation leukotriene B 4 (LTB 4 ) receptor antagonist SC-41930 (7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid) which has potent oral, topical
Autor:
D. J. Fretland, D. L. Widomski, Timothy S. Gaginella, James F. Kachur, T.J. Maziasz, C. P. Anglin, B.S. Tsai, Stella S. Yu, Tadimeti S. Rao, R. E. Walsh, R H Keith, Stephen H Docter, Stevan W. Djuric, D Villani-Price
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 4:811-816
The Structure Activity Relationship (SAR) studies leading to the identification of a novel high potency Leukotriene B4 receptor antagonist SC-53228 are delineated. This compound shows excelled pharmacodynamic efficacy in animal models of inflammatory
Autor:
R. F. Bauer, P. W. Collins, B.S. Tsai, R H Keith, R. G. Bianchi, W E Perkins, Alan F. Gasiecki, Robert L. Shone
Publikováno v:
Prostaglandins. 44:579-595
Prostaglandin E (PGE) receptors in canine small intestinal mucosal and muscle membrane preparations were labeled with [3H] PGE1. Saturable, high affinity binding of [3H] PGE1 was observed in both preparations. The density of binding sites (fmol/mg pr
Autor:
D Villani-Price, B.S. Tsai, R H Keith, Stevan W. Djuric, Thomas D. Penning, Julie M. Miyashiro
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 1:179-182
An enantioselective synthesis of a unique analogue of the pro-inflammatory eicosanoid Leukotriene B4 has been achieved in a convergent manner, from readily available starting materials. This analogue, 12-deoxy-12(S)-methyl LTB4, provides convincing e
Autor:
R. H. Keith, R. M. Hoover
Publikováno v:
Handbook of Noise and Vibration Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f37a45cf4e2607f6009dab64c82d413d
https://doi.org/10.1002/9780470172537.ch98
https://doi.org/10.1002/9780470172537.ch98
Autor:
B S, Tsai, R H, Keith, W E, Perkins, R E, Walsh, C P, Anglin, P W, Collins, A W, Gasiecki, R F, Bauer, P H, Jones, T S, Gaginella
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 275(1)
Prostaglandins (PGs) in the E-series exhibit potent gastric antisecretory activity, but can also cause diarrhea, which is mediated via PGE receptors. SC-46275, an omega-chain cyclopentenyl analog of the E-type PG enisoprost, was evaluated with other
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 268(3)
Previously, we reported that SC-41930 is a potent leukotriene B4 (LTB4) receptor antagonist. An analog of SC-41930, SC-51146, was evaluated as an antagonist of LTB4 receptors. SC-51146 was shown to bind to LTB4 high affinity binding sites on human ne
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 268(3)
SC-45694 (7-[4-(1-hydroxy-3Z-nonenyl)phenyl]-5S-hydroxy-6Z-hept enoic acid lithium salt), a representative of a new class of leukotriene B4 (LTB4) analogs that are conformationally restricted, was evaluated for effects on human neutrophil functions.
Autor:
D. L. Widomski, D. Spangler, James F. Kachur, S. W. Djuric, D. J. Fretland, Stella S. Yu, Stephen H. Docter, R H Keith, D Villani-Price, T. D. Penning, B.S. Tsai, C. P. Anglin
Publikováno v:
Agents and actions.
SC-41930, 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4- dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid, is a selective, orally active, LTB4 receptor antagonist currently in clinical trials for psoriasis and ulcerative colitis. Exhaustive